Usa covid-19 recommendations vaccine Usa

Interim Clinical Considerations for Use of mRNA COVID-19 Vaccines Currently Authorized in the United States

Reading now: 633
www.cdc.gov

Interim Considerations: Preparing for the Potential Management of Anaphylaxis at COVID-19 Vaccination SitesThe Advisory Committee on Immunization Practices (ACIP) has issued interim recommendations for the use of Pfizer-BioNTech and Moderna COVID-19 vaccines for the prevention of coronavirus disease 2019 (COVID-19) in the United States.

Both vaccines are lipid nanoparticle-formulated, nucleoside-modified mRNA vaccines encoding the prefusion spike glycoprotein of SARS-CoV-2, the virus that causes COVID-19.These interim CDC clinical considerations are informed by data submitted to the Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) of the vaccines, other data sources, general best practice guidelines for immunization,.

Read more on cdc.gov
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA